Filing Details

Accession Number:
0001209191-20-041549
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-07 19:13:36
Reporting Period:
2020-07-02
Accepted Time:
2020-07-07 19:13:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760682 Dashyant Dhanak 1801 Augustine Cut-Off
Wilmington DE 19803
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-02 6,661 $0.00 26,648 No 4 A Direct
Common Stock Disposition 2020-07-02 1,057 $106.47 25,591 No 4 F Direct
Common Stock Acquisiton 2020-07-06 961 $65.42 26,552 No 4 M Direct
Common Stock Disposition 2020-07-06 961 $106.58 25,591 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2020-07-02 12,743 $0.00 12,743 $106.47
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-07-06 961 $0.00 961 $65.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,743 2030-07-01 No 4 A Direct
35,564 2028-12-10 No 4 M Direct
Footnotes
  1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  2. Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  4. Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  5. Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
  6. Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.